Non-Opioid Pain Management Trials
With the opioid crisis driving a reassessment of pain management, clinical trials are testing novel non-opioid approaches including nav1.7 inhibitors (targeting a specific pain signalling channel), cannabinoid-based medicines, nerve growth factor (NGF) inhibitors, and digital pain management programmes. The NHS is actively recruiting for several of these trials.
Osteoporosis and Bone Health
Osteoporosis trials are testing next-generation anabolic bone agents (drugs that build new bone rather than just slowing loss), sclerostin inhibitors, and novel bisphosphonate formulations with improved safety profiles. UK fracture liaison services are key recruitment points for these trials.
Rehabilitation and Digital Therapeutics
A growing number of trials test digital approaches to musculoskeletal care: virtual reality physiotherapy, AI-guided exercise programmes, and remote monitoring via wearable sensors. These trials often accept participants who cannot easily attend hospital appointments, making them accessible across the UK.
📋 Conditions
⚖️ Comparisons
📰 Related Articles
- Chronic Pain Clinical Trials UK 2026 Guide — Guide to chronic pain and musculoskeletal research
- Osteoporosis Clinical Trials UK — Anabolic agents and bone-building treatments
- Rheumatoid Arthritis Clinical Trials UK — Biologics, JAK inhibitors, and precision medicine
Frequently Asked Questions
Find Your Clinical Trial
Search thousands of actively recruiting trials across the UK — free, instant, no registration.
Search Trials Now Read the Guide